A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia

Documents similaires

• Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia—Authors' Reply
  par: Maral Amangurbanova, et autres
  Publié: (2024)
• Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study
  par: Harris Siddiqi, et autres
  Publié: (2024)
• A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States
  par: Nikita Mittal, et autres
  Publié: (2024)
• Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study
  par: Federica Tavaglione, et autres
  Publié: (2025)
• The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
  par: Lana Bridi, et autres
  Publié: (2024)